pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Apr 23·1 min read
save

Sanofi defends Garijo appointment, says it is 'fully committed' to immunology

Sanofi’s first-quarter earnings call with the media on Thursday was an exercise in redirecting the narrative before its new CEO steps in next week. CFO François-Xavier Roger defended the company’s appointment of Merck KGaA’s Belén ...

Apr 23, 2026·read at Endpoints ↗

April 23, 2026 05:00 AM EDTUpdated 11:03 AM R&DPharma Up­dat­ed: Sanofi de­fends Gar­i­jo ap­point­ment, says it is 'ful­ly com­mit­ted' to im­munol­o­gy Ayisha Sharma News Reporter Sanofi’s first-quar­ter earn­ings call with the me­dia on Thurs­day was an ex­er­cise in redi­rect­ing the nar­ra­tive be­fore its new CEO steps in next week. CFO … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
85 words · retrieved Apr 26
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Sanofi4Sanofi4Merck KGaA
drugs
Immunology
topics
Immunology

related stories

  • Apr 23Sanofi posts upbeat sales as R&D pressure buildsBioPharma Dive
  • Jul 30Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continuesFierce Biotech
  • Apr 25Sanofi’s immunology reckoning; Lilly acquires in vivo CAR-T biotech; RevMed’s ‘Herceptin moment’; and moreEndpoints
  • Apr 24Sanofi MS drug rejected in US gets an endorsement in EuropeBioPharma Dive
  • Apr 23STAT+: Sanofi research priorities in flux as new CEO logs inSTAT